Muhsin H. Younis

573 total citations
17 papers, 389 citations indexed

About

Muhsin H. Younis is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Muhsin H. Younis has authored 17 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Molecular Biology. Recurrent topics in Muhsin H. Younis's work include Radiopharmaceutical Chemistry and Applications (4 papers), Peptidase Inhibition and Analysis (3 papers) and Immunotherapy and Immune Responses (3 papers). Muhsin H. Younis is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (4 papers), Peptidase Inhibition and Analysis (3 papers) and Immunotherapy and Immune Responses (3 papers). Muhsin H. Younis collaborates with scholars based in United States, China and India. Muhsin H. Younis's co-authors include Weibo Cai, Xiaoli Lan, Yongxue Zhang, Mengting Li, Weijun Wei, Jianjun Liu, Jonathan W. Engle, Todd E. Barnhart, Dalong Ni and Huilin Zhang and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and Advanced Functional Materials.

In The Last Decade

Muhsin H. Younis

17 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Muhsin H. Younis United States 10 171 116 113 100 58 17 389
Komal Mandleywala United States 10 115 0.7× 106 0.9× 159 1.4× 65 0.7× 52 0.9× 16 345
Wenyu Song China 10 114 0.7× 125 1.1× 57 0.5× 66 0.7× 36 0.6× 17 316
Renske J.E. van den Bijgaart Netherlands 11 223 1.3× 149 1.3× 63 0.6× 210 2.1× 76 1.3× 19 575
Shundong Ji China 13 122 0.7× 227 2.0× 149 1.3× 47 0.5× 64 1.1× 35 500
Liat Benayoun Israel 10 230 1.3× 172 1.5× 71 0.6× 128 1.3× 38 0.7× 11 486
Shi Gao China 11 134 0.8× 125 1.1× 181 1.6× 119 1.2× 63 1.1× 44 440
Lei Xin China 7 120 0.7× 59 0.5× 58 0.5× 138 1.4× 28 0.5× 17 334
Summer Y.Y. Ha Hong Kong 8 241 1.4× 140 1.2× 176 1.6× 101 1.0× 100 1.7× 11 466
Yong He China 15 205 1.2× 284 2.4× 68 0.6× 109 1.1× 37 0.6× 56 577
Kohei Nakajima Japan 14 87 0.5× 111 1.0× 94 0.8× 145 1.4× 150 2.6× 55 569

Countries citing papers authored by Muhsin H. Younis

Since Specialization
Citations

This map shows the geographic impact of Muhsin H. Younis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhsin H. Younis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhsin H. Younis more than expected).

Fields of papers citing papers by Muhsin H. Younis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muhsin H. Younis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhsin H. Younis. The network helps show where Muhsin H. Younis may publish in the future.

Co-authorship network of co-authors of Muhsin H. Younis

This figure shows the co-authorship network connecting the top 25 collaborators of Muhsin H. Younis. A scholar is included among the top collaborators of Muhsin H. Younis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muhsin H. Younis. Muhsin H. Younis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ghosh, Sanchita, Muhsin H. Younis, Avik Chakraborty, et al.. (2024). Brachytherapy at the nanoscale with protein functionalized and intrinsically radiolabeled [169Yb]Yb2O3 nanoseeds. European Journal of Nuclear Medicine and Molecular Imaging. 51(6). 1558–1573. 4 indexed citations
2.
Zhang, You, Min Cao, Yanfei Wu, et al.. (2024). Preclinical development of novel PD-L1 tracers and first-in-human study of [68Ga]Ga-NOTA-RW102 in patients with lung cancers. Journal for ImmunoTherapy of Cancer. 12(4). e008794–e008794. 23 indexed citations
3.
Huang, Wenpeng, et al.. (2023). Nuclear medicine radiomics in digestive system tumors: Concept, applications, challenges, and future perspectives. SHILAP Revista de lepidopterología. 4(6). 4 indexed citations
4.
Li, Mengting, Muhsin H. Younis, Yongxue Zhang, Weibo Cai, & Xiaoli Lan. (2022). Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond. European Journal of Nuclear Medicine and Molecular Imaging. 49(8). 2844–2868. 79 indexed citations
5.
Wang, Ya, Huilin Zhang, Yanyan Liu, et al.. (2022). Catalytic radiosensitization: Insights from materials physicochemistry. Materials Today. 57. 262–278. 37 indexed citations
6.
Li, Yuhan, Muhsin H. Younis, Han Wang, et al.. (2022). Spectral computed tomography with inorganic nanomaterials: State-of-the-art. Advanced Drug Delivery Reviews. 189. 114524–114524. 33 indexed citations
7.
Wei, Weijun, Muhsin H. Younis, Xiaoli Lan, Jianjun Liu, & Weibo Cai. (2022). Single-Domain Antibody Theranostics on the Horizon. Journal of Nuclear Medicine. 63(10). 1475–1479. 34 indexed citations
8.
Zhu, Xiang, Chunyuan Xue, Xiaofeng Kang, et al.. (2022). DNMT3B-mediated FAM111B methylation promotes papillary thyroid tumor glycolysis, growth and metastasis. International Journal of Biological Sciences. 18(11). 4372–4387. 34 indexed citations
9.
Younis, Muhsin H., Zhongmin Tang, & Weibo Cai. (2022). Multimodality imaging of nanoparticle‐based vaccines: Shedding light on immunology. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 14(5). e1807–e1807. 3 indexed citations
10.
Colombini, Marco, Kevin M. Barnes, Kai‐Ti Chang, Muhsin H. Younis, & Vicente M. Aguilella. (2022). Triplin: Functional Probing of Its Structure and the Dynamics of the Voltage-Gating Process. International Journal of Molecular Sciences. 23(22). 13765–13765. 1 indexed citations
11.
Wang, Yixin, et al.. (2022). Harnessing DNA for Immunotherapy: Cancer, Infectious Diseases, and Beyond. Advanced Functional Materials. 32(37). 16 indexed citations
12.
Li, Shiyong, Ye Wang, Muhsin H. Younis, et al.. (2022). Spleen‐Targeted Glabridin‐Loaded Nanoparticles Regulate Polarization of Monocyte/Macrophage (Mo/Mφ) for the Treatment of Cerebral Ischemia‐Reperfusion Injury. Advanced Materials. 34(39). e2204976–e2204976. 33 indexed citations
13.
Wang, Yuqi, Lingpu Zhang, Yan Liu, et al.. (2022). Engineering CpG‐ASO‐Pt‐Loaded Macrophages (CAP@M) for Synergistic Chemo‐/Gene‐/Immuno‐Therapy. Advanced Healthcare Materials. 11(15). e2201178–e2201178. 22 indexed citations
14.
Younis, Muhsin H., Xiaoli Lan, & Weibo Cai. (2021). PET with a68Ga-Labeled FAPI Dimer: Moving Toward Theranostics. Journal of Nuclear Medicine. 63(6). 860–861. 8 indexed citations
15.
Chen, Weiyu, Miao Li, Muhsin H. Younis, et al.. (2021). ImmunoPET of trophoblast cell-surface antigen 2 (Trop-2) expression in pancreatic cancer. European Journal of Nuclear Medicine and Molecular Imaging. 49(3). 861–870. 41 indexed citations
16.
Jin, Yuchen, Beibei Liu, Muhsin H. Younis, et al.. (2021). Next-Generation Molecular Imaging of Thyroid Cancer. Cancers. 13(13). 3188–3188. 9 indexed citations
17.
Song, Yangmeihui, Fang Liu, Weiwei Ruan, et al.. (2021). Head-to-Head Comparison of Neck 18F-FDG PET/MR and PET/CT in the Diagnosis of Differentiated Thyroid Carcinoma Patients after Comprehensive Treatment. Cancers. 13(14). 3436–3436. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026